Upper body high-intensity interval training for heart failure patients
The Effect of Upper Extremity Low-Volume High-Intensity Interval Training on Physical and Cognitive Functions in Heart Failure Patients
This study tests if a special type of exercise program for the upper body can help people with heart failure feel stronger and think better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Tarsus University Academic / other |
| Locations | 2 sites (Mersin, Mersin and 1 other locations) |
| Trial ID | NCT06754475 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of low-volume high-intensity interval training (LV-HIIT) on physical and cognitive function in patients with heart failure with preserved ejection fraction (HFpEF). It is designed as a randomized controlled trial where patients will be divided into an intervention group receiving LV-HIIT and a control group receiving standard medical treatment. The intervention consists of structured exercise sessions on an arm ergometer over 8 weeks, focusing on improving exercise capacity and cognitive functions. Evaluations will include physical function assessments, muscle strength, fatigue, and mental health indicators before and after the intervention.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old with stable heart failure classified as New York Heart Association functional class I-II to III.
Not a fit: Patients with severe heart conditions or significant comorbidities that affect exercise capacity may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance physical and cognitive functions in heart failure patients, improving their overall quality of life.
How similar studies have performed: Other studies have shown promising results with high-intensity interval training in heart failure populations, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical condition stable for ≥4 weeks. * New York Heart Association functional classification I-II to III * Over 18 years old Exclusion Criteria: History of CABG surgery * Unstable angina pectoris * Severe arrhythmia * Acute pericarditis, endocarditis, myocarditis * Severe left ventricular failure (EF \<40%) * Acute pulmonary embolism * History of syncope * Dissecting aneurysm * Thrombophlebitis * Orthopedic disorders that may interfere with exercise * Uncontrolled hypertension, severe pulmonary arterial hypertension * Moderate-severe valve disease * Decompensated Congestive Heart Failure * Electrolyte abnormalities * Hypertrophic Cardiomyopathy
Where this trial is running
Mersin, Mersin and 1 other locations
- Tarsus University, TARSUS, Mersin — Mersin, Mersin, Turkey (Türkiye) (Recruiting)
- Nurel Ertürk, TARSUS, Mersin — Yenişehir, Mersin, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Nurel ERTÜRK
- Email: nrlbllr@gmail.com
- Phone: +905056637544
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.